← Back to ALXO

ALX Oncology Holdings Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 06/08/2026Mar 2026Filed 06/08/2026Sep 2025Filed 07/11/2025Jun 2025Filed 06/08/2026Mar 2025Filed 06/08/2026Sep 2024Filed 07/11/2025Jun 2024Filed 07/11/2025Mar 2024Filed 07/11/2025
−$18−$18−$22−$26−$31−$31−$39−$36
−$0.13−$0.17−$0.41−$0.49−$0.58−$0.58−$0.76−$0.71
136105545353535250

Trend

Net income

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.